ALPKF yields 9.38% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, ALPKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALPKF + JNJ for your $10,000?
Alpek, S.A.B. de C.V., together with its subsidiaries, operates as a petrochemical company in Mexico, the United States, Canada, the United Kingdom, Argentina, Brazil, and Chile. It operates in two segments, Polyester, and Plastics and Chemicals. The Polyester segment produces purified terephthalic acid for use as a raw material in polyethylene terephthalate (PET) and polyester fibers; PET, a plastic resin for use in the beverage bottles, food containers, and consumer good packaging applications; and recycled PET for use in new bottles and containers, strapping and packing supplies, and fibers for clothing and carpet. This segment also offers polyester fibers, such as staple fiber for use in carpets, garments, and home furnishings; and filament for clothing, automotive interiors, and seatbelts, as well as canvases, conveyor belts, hoses, and other industrial uses. The Plastics and Chemicals segment manufactures polypropylene, expandable polystyrene, caprolactam, and other chemicals, as well as specialty and industrial chemicals for use in the consumer goods, food and beverage packaging, automotive, construction, agriculture, oil, and pharmaceutical industries. The company was founded in 1975 and is based in San Pedro Garza García, Mexico. Alpek, S.A.B. de C.V. is a subsidiary of Alfa, S. A. B. de C. V.
Full ALPKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.